Oxygen and surgical site infection: A study of underlying immunologic mechanisms

Anesthesiology

Volumn 113, Issue 2, 2010, Pages 369-377

  Qadan, Motaz ^a   Battista, Christopher ^a   Gardner, Sarah A ^a   Anderson, Gary ^b   Akca, Ozan ^a   Polk, Hiram C ^a  

^a University of Louisville School of Medicine   (United States)

^b Outcomes Research Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; OXYGEN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYPEROXIA; IMMUNOREACTIVITY; INFECTION RESISTANCE; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SURGICAL INFECTION;

EID: 77955173773     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181e19d1d     Document Type: Article

References (42)

1. Akca O, Sessler DI: Supplemental oxygen and risk of surgical site infection. JAMA 2004; 291:1956-1957
2. Polk HC Jr, Lopez-Mayor JF: Postoperative wound infection: A prospective study of determinant factors and prevention. Surgery 1969; 66:97-103
3. Qadan M, Gardner SA, Vitale DS, Lominadze D, Joshua IG, Polk HC Jr: Hypothermia and surgery: Immunologic mechanisms for current practice. Ann Surg 2009; 250:134-140
4. Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, Wright C, Ma A, Carr K, Red L: Use of antimicrobial prophylaxis for major surgery: Baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005; 140:174-182
5. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP: The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326:281-286
6. Kurz A, Sessler DI, Lenhardt R: Perioperative normother-mia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334:1209-1215
7. Dellinger EP: Increasing inspired oxygen to decrease surgical site infection: Time to shift the quality improvement research paradigm. JAMA 2005; 294:2091-2092
8. Tornero-Campello G: Hyperoxia to reduce surgical site infection? ANESTHESIOLOGY 2007; 106:632-633
9. Chura JC, Boyd A, Argenta PA: Surgical site infections and supplemental perioperative oxygen in colorectal surgery patients: A systematic review. Surg Infect (Larchmt) 2007; 8:455-461
10. Qadan M, Akca O, Mahid SS, Hornung CA, Polk HC Jr: Perioperative supplemental oxygen therapy and surgical site infection: A meta-analysis of randomized controlled trials. Arch Surg 2009; 144:359-366
11. Belda FJ, Aguilera L, Garcia de la AJ, Alberti J, Vicente R, Ferrandiz L, Rodriguez R, Company R, Sessler DI, Aguilar G, Botello SG, Orti R: Supplemental perioperative oxygen and the risk of surgical wound infection: A randomized controlled trial. JAMA 2005; 294:2035-2042
12. Greif R, Akca O, Horn EP, Kurz A, Sessler DI: Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med 2000; 342:161-167 (Pubitemid 30051647)
13. Mayzler O, Weksler N, Domchik S, Klein M, Mizrahi S, Gurman GM: Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery? Minerva Anestesiol 2005; 71: 21-25
14. Myles PS, Leslie K, Chan MT, Forbes A, Paech MJ, Peyton P, Silbert BS, Pascoe E: Avoidance of nitrous oxide for patients undergoing major surgery: A randomized controlled trial. ANESTHESIOLOGY 2007; 107:221-231
15. Pryor KO, Fahey TJ III, Lien CA, Goldstein PA: Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: A randomized controlled trial. JAMA 2004; 291:79-87
16. Gardella C, Goltra LB, Laschansky E, Drolette L, Magaret A, Chadwick HS, Eschenbach D: High-concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: A randomized controlled trial. Obstet Gynecol 2008; 112:545-552
17. Maragakis LL, Cosgrove SE, Martinez EA, Tucker MG, Cohen DB, Perl TM: Intraoperative fraction of inspired oxygen is a modifiable risk factor for surgical site infection after spinal surgery. ANESTHESIOLOGY 2009; 110:556-562
18. Meyhoff CS, Wetterslev J, Jorgensen LN, Henneberg SW, Hogdall C, Lundvall L, Svendsen PE, Mollerup H, Lunn TH, Simonsen I, Martinsen KR, Pulawska T, Bundgaard L, Bugge L, Hansen EG, Riber C, Gocht-Jensen P, Walker LR, Bendtsen A, Johansson G, Skovgaard N, Helto K, Poukinski A, Korshin A, Walli A, Bulut M, Carlsson PS, Rodt SA, Lundbech LB, Rask H, Buch N, Perdawid SK, Reza J, Jensen KV, Carlsen CG, Jensen FS, Rasmussen LS: Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: The PROXI randomized clinical trial. JAMA 2009; 302: 1543-1550
19. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA: Flow cytometric analysis of the granulocyte respiratory burst: A comparison study of fluorescent probes. J Immunol Methods 1995; 178:89-97
20. Hopf HW, Hunt TK, West JM, Blomquist P, Goodson WH III, Jensen JA, Jonsson K, Paty PB, Rabkin JM, Upton RA, von Smitten K, Whitney JD: Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997; 132:997-1004
21. Allen DB, Maguire JJ, Mahdavian M, Wicke C, Marcocci L, Scheuenstuhl H, Chang M, Le AX, Hopf HW, Hunt TK: Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997; 132:991-996
22. Hunt TK, Linsey M, Sonne M, Jawetz E: Oxygen tension and wound infection. Surg Forum 1972; 23:47-49
23. Hedenstierna G: Atelectasis and its prevention during anaesthesia. Eur J Anaesthesiol 1998; 15:387-390
24. Rothen HU, Sporre B, Engberg G, Wegenius G, Reber A, Hedenstierna G: Prevention of atelectasis during general anaesthesia. Lancet 1995; 345:1387-1391
25. Akca O, Podolsky A, Eisenhuber E, Panzer O, Hetz H, Lampl K, Lackner FX, Wittmann K, Grabenwoeger F, Kurz A, Schultz AM, Negishi C, Sessler DI: Comparable postoperative pulmonary atelectasis in patients given 30% or 80% oxygen during and 2 hours after colon resection. ANESTHESIOLOGY 1999; 91:991-998
26. Miles AA, Miles EM, Burke J: The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol 1957; 38:79-96
27. Wenisch C, Narzt E, Sessler DI, Parschalk B, Lenhardt R, Kurz A, Graninger W: Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes. Anesth Analg 1996; 82: 810-816
28. Bardosi L, Tekeres M: Impaired metabolic activity of phagocytic cells after anaesthesia and surgery. Br J An-aesth 1985; 57:520-523
29. Moudgil GC, Pandya AR, Ludlow DJ: Influence of anaesthesia and surgery on neutrophil chemotaxis. Can Anaesth Soc J 1981; 28:232-238
30. Nunn JF, O'Morain C: Nitrous oxide decreases motility of human neutrophils in vitro. ANESTHESIOLOGY 1982; 56:45-48
31. Knighton DR, Halliday B, Hunt TK: Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 1986; 121:191-195
32. Mandell GL: Bactericidal activity of aerobic and anaerobic poly-morphonuclear neutrophils. Infect Immun 1974; 9:337-341
33. Smith JA, Weidemann MJ: Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 1993; 162:261-268
34. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-871
35. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-664
36. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial TNF-alpha MAb Sepsis Study Group. JAMA 1995; 273: 934-941
37. Abraham E, Anzueto A, Gutierrez G, Tessler S, San PG, Wunderink R, Dal NA, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NO-RASEPT II Study Group. Lancet 1998; 351:929-933
38. Van der Poll T: Immunotherapy of sepsis. Lancet Infect Dis 2001; 1:165-174
39. Arndt P, Abraham E: Immunological therapy of sepsis: Experimental therapies. Intensive Care Med 2001; 27(suppl 1): S104-15
40. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11:161-167
41. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC Jr: HLA-DR antigen expression on peripheral blood mono-cytes correlates with surgical infection. Am J Surg 1991; 161:639-645
42. Tsai AG, Johnson PC, Intaglietta M: Oxygen gradients in the microcirculation. Physiol Rev 2003; 83:933-963